Ticker
MDWD
MediWound Ltd.
MDWD — smart-money forecast & insider signals
Forecast & smart-money signals — answered with data, not hype.
Three insiders bought ~$136k in 60 days; smart-money score moderate at 66/100.
A factual summary of what the smart money is doing — not a buy recommendation.
Risk flags the hype pages skip
🚀 Is it really the next 10x?
✓ What resembles it
- ✓Insider buying signals management believes stock undervalued or near inflection point.
- ✓Small-cap biotech/medical device sector historically produces outsized winners from niche
- ✓No major whale shorting or institutional dumping visible in current snapshot.
✕ What's different
- ✕No major institutional whale backing (13F); limits capital acceleration and visibility.
- ✕Insider buys modest ($136k across 3 people); not conviction-level accumulation.
- ✕Score 66/100 is solid but not exceptional; lacks hallmarks of breakout setup.
10x is rare—fewer than 1% of stocks achieve it. Insider buying + moderate smart-money score suggests insiders see value, but that's not a catalyst guarantee.
Get the next one before the crowd
We scan 4,000+ small-caps for exactly these smart-money signals. Free, weekly.
Send me the picks →Overview
MediWound Ltd. (MDWD) is on the TradesZ smart-money radar. This page tracks insider buying, fund positioning and balance-sheet risk flags from SEC filings.
Everyone wishes they'd bought Nvidia early. Here's how to spot the next one.
The biggest winners of the last decade had one thing in common. Our data follows those exact moves — and turns them into 10 names to watch right now.
The big names in the AI, Space, Nuclear and Robotics race. The window to get in early is closing fast. Don't wait.
Data sources & methodology
All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →
TZ Researched & published by TradesZ Research
Tier L — We track this ticker but don't publish active deep-dive coverage. Want us to follow it? Sign up for the newsletter and we'll look at promotion to Tier M or S if it surfaces in our pipeline.
Want our premium picks too?
Pro subscribers get our strongest pre-pop ideas + real-time buy-zone alerts.
Read more about PremiumBefore you buy anything —
See the 10 stocks our team is most bullish on right now — under-the-radar names we believe have monster upside potential, in plain English. Free.
Show me the 10 stocks — free →Not investment advice. We share research and analyses for educational purposes. Investing in stocks involves risk, including possible loss of capital. Always do your own research.